Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results
Nov 13, 2017 12:30 pm UTC| Business
IRVING, Texas, Nov. 13, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2017,...
Development of Therapeutic Monoclonal Antibody Products 2017-2021
Nov 13, 2017 12:26 pm UTC| Business
Dublin, Nov. 13, 2017 -- The "The Development of Therapeutic Monoclonal Antibody Products" report has been added to Research and Markets' offering. As the pharmaceutical market in the United States...
NI Holdings, Inc. Files Third Quarter 2017 Results
Nov 13, 2017 12:15 pm UTC| Business
FARGO, North Dakota, Nov. 13, 2017 -- NI Holdings, Inc. (NASDAQ:NODK) today reported its financial results for the quarter ended September 30, 2017. Significant items included: Net loss attributable to NI Holdings of...
Nov 13, 2017 12:05 pm UTC| Business
HALIFAX, Nova Scotia, Nov. 13, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the Society for Immunotherapy of Cancer (SITC) has recognized...
Nov 13, 2017 12:02 pm UTC| Business
Dublin, Nov. 13, 2017 -- The "Cancer Liquid Biopsy Market Assessment" report has been added to Research and Markets' offering. The term liquid biopsy encompasses various diagnostic methods that use...
Nov 13, 2017 12:01 pm UTC| Business
PRESS RELEASE Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate ~ Data shows a 73% one-year survival rate for...
Nov 13, 2017 12:00 pm UTC| Business
Key Updates The first patient has received the first dose of QR-110 in the Phase 1/2 safety efficacy clinical trial (PQ-110-001: NCT03140969) in children and adults with Leber’s congenital amaurosis 10 (LCA 10).LCA 10...